Cy5 Fluc mRNA(5’CAP) |
| Catalog No.GM10014 |
Cy5 Fluc mRNA (5'CAP) is a luciferase mRNA transcribed in vitro by simulating mRNA processing in eukaryotes. Cy5 Fluc mRNA (5'CAP) carries the Cy5 label (Cy5-UTP:UTP=3:1 (molar ratio)), Cap 1 cap structure, and poly (A) tail, and can effectively inhibit RNA mediated innate immune activation.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Cy5 Fluc mRNA (5'CAP) is a luciferase mRNA transcribed in vitro by simulating mRNA processing in eukaryotes. Cy5 Fluc mRNA (5'CAP) carries the Cy5 label (Cy5-UTP:UTP=3:1 (molar ratio)), Cap 1 cap structure, and poly (A) tail, and can effectively inhibit RNA mediated innate immune activation. Cy5 Fluc mRNA (5'CAP) can be used as a standard to detect the transfection efficiency of different transfection reagents, and can also be used as a control to study the transfection, localization, and expression of fluorescent proteins in mammalian cells.
The luciferase reporter gene (Fluc) can detect gene expression extremely sensitively and efficiently, and is therefore commonly used as a bioluminescence reporter gene for gene regulation and functional research. Cy5 Fluc mRNA (5'CAP) can directly express proteins in the cytoplasm without relying on promoters, with a faster protein expression rate than transfected DNA. The protein expression level is directly related to the mRNA transfection level, and there is no risk of gene integration. Firefly luciferase protein catalyzes the spontaneous fluorescence of intracellular luciferin or fatty aldehydes, producing chemiluminescence at a wavelength of approximately 550-570nm[1]. Cy5 is a commonly used cyanine fluorescent dye, with maximum excitation/emission wavelengths of 650/670nm, respectively.
Firefly luciferase can be used to detect promoter activity or double fluorescent molecule complementarity experiments. Firefly luciferase and sea kidney luciferase can catalyze their respective substrates to emit fluorescence of different colors, and the two light absorption wavelengths are different, so they do not interfere with each other in detection. Therefore, they can be used simultaneously as dual luciferase reporter gene systems in the same chemical reaction system[2].
References:
[1]. JoÃo M M LeitÃo, Joaquim C G Esteves da Silva. Firefly luciferase inhibition. 2010 Oct 5;101(1):1-8. doi: 10.1016/j.jphotobiol.2010.06.015. Epub 2010 Jul 3.
[2]. Yong Zhong Xu, et. Promoter deletion analysis using a dual-luciferase reporter system.2013;977:79-93. doi: 10.1007/978-1-62703-284-1_7.
| mRNA Length | 1929 nucleotides | ||
| Concentration | 1mg/mL | ||
| Buffer | DEPC-Treated Water | Storage | -40°C or below |
| General tips | Please dissolve it on ice and be careful to prevent RNase contamination and degradation. Avoid repeated freezing and thawing as much as possible. Do not vortex. For first use, gently centrifuge and divide into portions for individual use. Use RNase-free reagents and consumables, use appropriate RNase-free techniques, and do not add to the serum-containing medium until mixed with the transfection reagent. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *